Home > Compound List > Product Information
m-Toluenesulfonyl chloride_Molecular_structure_CAS_1899-93-0)
Click picture or here to close

m-Toluenesulfonyl chloride

Catalog No. 566357 Name Sigma Aldrich
CAS Number 1899-93-0 Website http://www.sigmaaldrich.com
M. F. C7H7ClO2S Telephone 1-800-521-8956
M. W. 190.64728 Fax
Purity 97% Email
Storage Chembase ID: 9745

SYNONYMS

Title
间甲苯磺酰氯
IUPAC name
3-methylbenzene-1-sulfonyl chloride
IUPAC Traditional name
3-methylbenzenesulfonyl chloride
Synonyms
3-Methylbenzenesulfonyl chloride

DATABASE IDS

CAS Number 1899-93-0
MDL Number MFCD00051747
PubChem SID 24880292

PROPERTIES

Linear Formula CH3C6H4SO2Cl
Purity 97%
Boiling Point 252-253 °C(lit.)
Density 1.314 g/mL at 25 °C(lit.)
Flash Point 107 °C
Flash Point 224.6 °F
Refractive Index n20/D 1.5490(lit.)
GHS Pictograms GHS05
GHS Signal Word Danger
GHS Hazard statements H314
European Hazard Symbols Corrosive Corrosive (C)
MSDS Link Download
Personal Protective Equipment Faceshields, full-face respirator (US), Gloves, Goggles, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS Precautionary statements P280-P305 + P351 + P338-P310
RID/ADR UN 3265 8/PG 2
Risk Statements 34
Safety Statements 26-36/37/39-45
Hazard Class 8
UN Number 3265
Packing Group 2
German water hazard class 3

DETAILS

Description (English)
Packaging
5, 25 g in glass bottle
Application
Reactant involved in they synthesis of biologically active molecules including:
• Small molecule ligands for the Stat3 SH2 domain1
• Isoindoline-5-propenehydroxamates for use as histone deactylase inhibitors2
• Phenyl-pyrazolylamine-based derivatives as FLT3 kinase inhibitors3
• Aryldisulfonamides with antibacterial activity4
• Quinazoline analogs for the treatment of Gaucher disease5
• 17β-HSD2 inhibitors for the treatment of osteoporosis6
Description (简体中文)
包装
5, 25 g in glass bottle
Application
Reactant involved in they synthesis of biologically active molecules including:
• Small molecule ligands for the Stat3 SH2 domain1
• Isoindoline-5-propenehydroxamates for use as histone deactylase inhibitors2
• Phenyl-pyrazolylamine-based derivatives as FLT3 kinase inhibitors3
• Aryldisulfonamides with antibacterial activity4
• Quinazoline analogs for the treatment of Gaucher disease5
• 17β-HSD2 inhibitors for the treatment of osteoporosis6

REFERENCES